Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOSITIONS AND METHODS COMPRISING KLK3, PSCA, OR FOLH1 ANTIGEN
Document Type and Number:
Japanese Patent JP2016187340
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide compositions and methods to enhance the immunogenicity of antigens useful in the prevention and treatment of prostate tumors.SOLUTION: The present invention provides kallikrein-related peptidase 3 (KLK3) peptides, recombinant polypeptides comprising the same, recombinant nucleotide molecules encoding the same, recombinant Listeria strains comprising the same, and immunogenic and therapeutic methods utilizing the same. The non-KLK3 peptide is an ActA peptide or a PEST sequence peptide. The amino acid sequence of the KLK3 peptide includes a sequence selected from 10 specific sequences, and the non-KLK3 peptide enhances the immunogenicity of the recombinant polypeptide in the recombinant Listeria strain.SELECTED DRAWING: Figure 1

Inventors:
YVONNE PATERSON
JOHN ROTHMAN
VAFA SHAHABI
Application Number:
JP2016090433A
Publication Date:
November 04, 2016
Filing Date:
April 28, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV PENNSYLVANIA
ADVAXIS INC
International Classes:
C12N15/09; A61K31/7088; A61K35/74; A61K38/46; A61K39/00; A61K39/39; A61K48/00; A61P15/00; A61P35/00; A61P37/04; C07K7/08; C07K14/195; C07K19/00; C12N1/20; C12N1/21; C12N9/64
Domestic Patent References:
JP2014064569A2014-04-17
JP2010507485A2010-03-11
JP2013219162A2013-10-24
Foreign References:
WO2006017856A22006-02-16
WO2007015704A22007-02-08
US20060269561A12006-11-30
WO2008140812A22008-11-20
WO2003031569A22003-04-17
WO2003076610A22003-09-18
US20050266530A12005-12-01
WO2005052593A12005-06-09
WO2000049158A22000-08-24
Other References:
ARCH. OTOLARYNGOL. HEAD NECK SURG., 2004, VOL.130, P.92-97, JPN6018013975
DATABASE GENBANK [ONLINE], ACCESSION NO.AAY54611, ACTA [LISTERIA MONOCYTOGENES], LAST UPDATED ON 200, JPN6018013978
DATABASE UNIPROT [ONLINE], ACCESSION NO.Q8NCW4, DEFINITION:PROSTATE SPECIFIC ANTIGEN PRECURSOR, LAST, JPN6018013980
Attorney, Agent or Firm:
Yoichi Oshima